The efficacy of renal-dose dopamine to improve renal function or reduce renal impairment was studied in 52 patients undergoing elective coronary artery bypass surgery. The patients were prospectively randomised in a double-blind fashion to receive dopamine at 200 p.g/min (group D) or placebo (group P) from induction for 24 hours. Although dopamine improved haemodynamics, there was no effect on urine output at 4 hours (D=917, P=1231 ml: P=0.066); urine output at 24 hours (D=3659, P=3304 ml: P=0.36); creatinine clearance at 0-4 hours (D=104, P=127 mllmin: P=0.27); creatinine clearance on admission to ICU-4 hours (D= 94.8, P=83.4 mllmin: P = 0.48); creatinine clearance at 20-24 hours (D = 91.2, P= 107 mllmin: P=0.48); free-water clearance at 0-4 hours (D = 29.6, P= -59.8 mllhr: P=0.069);free-water clearance at 20-24 hours (D=43.2, P= -48.9 mllhr: P = 0.55). The incidence of transient renal impairment was similar in both groups (D=36%, P=50%: P = 0.65).
The incidence of renal impairment following cardiac surgery is 5OJo to 30OJo and is associated with a high mortality (up to 65OJo). [1] [2] [3] [4] [5] Commonly used indicators of renal function following surgery are urine output or serum creatinine. A more accurate assessment can be achieved using creatinine clearance, and an earlier indicator may be free-water clearance. 6 • 7 Diuretics have traditionally been used to promote urine flow with the belief that this will reduce the incidence of renal impairment: mannitol has the disadvantage of unwanted volume loading, frusemide has the disadvantage of ototoxicity.8 Neither drug may be effective in preventing renal failure, despite their proven effect as diuretics. 3 ,9-I2 Low-dose dopamine (= "renal-dose": 1-3 jlg/kg/min) has been found to be superior to either of these drugs, proving beneficial in oliguric states. [13] [14] [15] [16] [17] Renal-dose dopamine has the added benefit of a small increase in cardiac index, which counteracts the haemodynamic effects of positive pressure ventilation and anaesthesia. 13 Despite the theoretical advantages of using low-dose dopamine routinely in cardiac surgery, we could not find any published prospective, randomised studies investigating this therapy. The aim of this study was to determine if routine prophylactic renal-dose dopamine preserved renal function during and after cardiac surgery.
MATERIALS AND METHODS
The sample was selected from elective patients booked for coronary artery bypass surgery, who gave written, informed consent. This study was approved by our Hospital Ethics Review Committee. It was a prospective, double-blind, randomised trial consisting of two groups: 1. control group-5OJo dextrose, 50 ml at 3 mllhr; 2. dopamine group-dopamine 200 mg in 5OJo dextrose, 50 ml also at 3 mllhr (i.e. 200 jlg/min, or 3 jlg/kg/min for a patient weighing 66.7 kg). The infusion was commenced at induction and ran for 24 hours.
Patients were randomised into either group according to a table of random numbers, arranged by the hospital Pharmacy Department. The coded 50 ml syringes were prepared by pharmacy, with the contents remaining unknown by the investigators until the end of the trial.
Patients were excluded if they had pre-existing renal failure (defined as serum creatinine> 300 jlmolllitre), had infective endocarditis, or where dopamine was contraindicated: phaeochromocytoma, hyper-thyroidism, tachyarrhythmias. Patients were also excluded if the trial protocol was breached. No patient was given anti-dopaminergic drugs (metoclopramide, chlorpromazine, haloperidol) during the study period.
All patients received a standard general anaesthetic: premedication consisted of oral temazepam 10-20 mg, morphine 5-10 mg IM, hyoscine 0.2-0.4 mg IM: induction; diazepam 10-20 mg IV, fentanyl 0.5-1.5 mg, pancuronium 8-12 mg: maintenance; oxygen/air, enflurane 0.2-0.8070 and fentanyl 0.5-1.5 mg. The patient's ventilation was set to a tidal volume 10 mllkg and initial rate lO/min (adjusted to maintain an endtidal CO 2 of 32-34 mmHg); PEEP was not used.
All intravascular cannulations (intravenous, arterial and central venous) were performed before induction, with the use of sedation and local anaesthetic infiltration. All patients received one litre of isotonic crystalloid before bypass; more fluids were given if required to maintain an adequate filling pressure.
A sample of urine was collected from the catheter bag following induction, before antibiotic administration, to exclude pre-existing urinary tract infection. A colony count exceeding 10 3 /ml was assumed to be due to infection, and the patient excluded from analysis.
Cardiopulmonary bypass (CPB) was standardised (see Table 1 ). Standard technique of cardiopulmonary bypass crystalloid(2500ml)/plasma(500ml) prime membrane oxygenator arterial line filter (20 micron) no mannitol added blood cardioplegia hypothermia (25-27 QC) alpha-stat pH management non-pulsatile flow, rates: 2.4 1 min -I.m -2 at 37 DC 1.8 1 minl .m-2 at 25 D C mean pressure: 50-70 mmHg added volume (blood, crystalloid) as indicated Following induction of general anaesthesia, the trial syringe pump infusion was commenced at 3 mllhr and continued for 24 hours at the same rate. Medical staff treating the patient were asked to follow a protocol of diuretic administration if a patient was oliguric (defined as two consecutive hours of urine production < 0.5 ml . kg-I . hr-I with a pulmonary capillary wedge pressure > 12 mmHg (see Table 2 ).
Use of diuretics (number of doses and total dose) was documented. If dopamine was required for persisting oliguria (Table 2) , subsequent results were excluded from analysis. Blood, colloid and crystalloid administration were left to the discretion of the medical Anaesthesia and Intensive Care, Vol. 21, No. I, February, 1993 staff caring for the patient. All patients received a glyceryl trinitrate infusion following CPB (30-80 j.tg/min). Inotrope infusions (adrenaline, noradrenaline) were used if clinically indicated; such use was documented and analysed. Assessment of renal function (outcome) involved standard measurements that are currently used for routine patient care after cardiac surgery: fluid balance, urine output, daily serum creatinine (day 0= admission to ICU, days 1, 2 and 7). Fluid balance was calculated by adding crystalloid (including drug volumes and flush lines), colloid and blood administration and subtracting urine output, blood loss and nasogastric losses. Additional tests were also performed: (a) at four hours post-induction; serum osmolality, urine osmolality, creatinine clearance (4-hour period): (b) on return to ICU; creatinine clearance (4-hour period): (c) at 20-24 hours post-induction; serum osmolality, urine osmolality, creatinine clearance (4-hour period). To avoid interference with other drugs (notably cephalosporins), the enzymatic method was used for creatinine determinations.
Renal impairment was defined as > 25070 increase in serum creatinine, and renal failure as serum creatinine > 300 j.tmollml.
Free-water clearance was calculated by the formula: CH20 = UV(I-UOsm/POsm) where UV = urine volume (mllhr) CH20 = free-water clearance (mllhr) UO sm = urine osmolality (mOsm/l) PO sm = plasma osmolality (mOsm/l) Haemodynamic and perfusion data were tabulated as per normal practice. Haemodynamic indices were measured/calculated at frequent intervals, using the Hewlett-Packard Component Monitoring System (HP M1176A, Hewlett-Packard GmBH, Hamburg, Germany). Cardiac output was measured using a standard thermodilution technique (intra-operative: manual injection of 10 ml room temperature saline; postoperative: 5 ml ice cold saline; both at end-expiration, in triplicate).
Requirement for dialysis or haemofiltration were recorded, as was the seven-day mortality rate.
A preliminary estimate of sample size was based on an expected deterioration of 30070, with creatinine clearance of 90 mllmin and an estimated standard deviation of 30 mllmin. We calculated a sample size of 50 patients to achieve a type 11 error < 0.2, with a type 1 error < 0.05 (Clinical Trials Design Program V1.0, Biosoft, Cambridge, UK). Missing data were included in the analysis. Results are presented as mean (SD). All statistical analyses were performed using the SPSS/PC+ V4.0 computer program (SPSS Inc., Sydney, Australia). Comparison was made between the groups. Continuous data were analysed using one-way analysis of variance with Tukey's alternative test for multiple comparisons, after ensuring equality of variance and normal distribution of data. Data not normally distributed were analysed using Kruskall-Wallis analysis of variance. Ordinal data were analysed using Mann-Whitney u test; categorical data were analysed using Chi-squared analysis with Yates' correction or Fisher's exact test (as indicated). Pearson correlation coefficients (r) were calculated for preand postoperative cardiac index versus the above measurements of renal function. A P value of < 0.05 was considered statistically significant.
RESULTS
A total of 52 patients were enrolled in the study over a period of three months. All eligible patients (according to the study protocol) were approached. There were three withdrawals (one patient withdrew consent before commencement of surgery after discussion with their spouse, one patient was haemofiltered during cardiopulmonary bypass to correct dilutional anaemia, one patient required an intra-aortic balloon pump following return to the operating theatre for continued bleeding and pericardial tamponade). Of the remaining patients, 25 had been randomised to the dopamine group and 24 to the control group (see Table  3 ). There were 37 male (approx. 75070) and 12 female patients, with a mean age of 61.5 (9.0) years, weight 75. 8 Dopamine had a small but significant effect on haemodynamics, particularly following induction and CPB (see Table 4 ). A trend of improved haemodynamic parameters can also be seen at 8 and 16 hours following induction, but these are not significant.
The renal effects of dopamine are summarised in Table 5 . Both groups had received similar fluid input over the 24-hour period of study, with equal measured blood loss. Both groups received a similar dose of metaraminol during CPB to maintain perfusion pressure above 50 mmHg (dopamine group 2.3 mg, control group 2.1 mg, P=0.87). Using the separate measurements of urine output, daily serum creatinine, repeated creatinine and free-water clearance estimations, there were no significant differences in postoperative renal function or outcome. Three patients in each group were given a single dose of frusemide during the study period, X 2 =0.25, P=0.61. There were no exclusions due to dopamine (according to protocol) requirement. No patient developed renal failure nor required dialysis or haemofiltration during the period of hospitalisation. The incidence of transient renal impairment was similar (dopamine group 36070, control group 50070, X2=0.33, P=0.65). No patient was found to have a pre-existing urinary tract infection. The sevenday mortality rate was zero.
There was no significant correlation between the patient's cardiac index with creatinine or free-water clearance (r range: 0.21 to 0.40, median -0.01). There was also no significant correlation between aortic crossclamp time and free-water (r = -0.15) or creatinine clearance (r=0.15).
Ten patients in the control group and nine in the dopamine group were placed on other inotrope infusions (adrenaline or noradrenaline) during the post-CPB period. When our renal parameters were analysed separately for these patients, similar nonsignificant results were found.
DISCUSSION
Our study failed to demonstrate that routine perioperative use of renal-dose dopamine is associated with improvement in renal function or prevention of transient renal impairment in patients undergoing elective coronary artery surgery.
The most frequently used indicators of renal function after surgery are urine output and serum creatinine; neither of these were improved with dopamine. More sensitive tests of renal function were also unaltered. The previously demonstrated 14,17-19 haemodynamic effects (increased cardiac index, decreased systemic vascular resistance index) were seen with dopamine. Previous studies have demonstrated improvement in renal functionfo/lowing adult cardiac surgery!4 (after a period of oliguria) and paediatric cardiac surgery,17 and for liver transplantation surgery. 18 There have also been several case reports highlighting the beneficial effect of dopamine in the prevention of acute renal failure. 13,ll Davis et al. 14 demonstrated improvement in renal function (creatinine, osmolar and free-water clearances) in a group of 15 adult cardiac surgical patients given low-dose {lOO and 200 {tg/min) dopamine infusion following a period of oliguria after CPB. However, no control group was included in this unblinded study. Girardin et al. 17 studied 14 children after cardiac surgery and found that an infusion of dopamine at 5 {tg/kg/min increased cardiac output, renal plasma flow and glomerular filtration rate, thus decreasing the filtration fraction. At 2.5 {tg/kg/min there was only an effect on renal plasma flow, and only in patients over five years of age. They concluded that a dopamine infusion of 5 {tg/kg/min after cardiac surgery could prevent renal failure. However, this study also lacked blinding and a control group. In the study by Poison et al. 18 on patients undergoing liver transplantation, they found a benefit with low-dose dopamine (2 {tg/kg/min) commenced before surgery; the dopamine group had a higher urine output, higher creatinine clearance and less renal impairment. Despite cautioning against the applicability of their findings with other surgery (use of cyclosporin A, massive transfusion requirements), they suggest that a similar protocol may be of benefit with other major surgical procedures where patients are at risk of developing acute renal failure. Coronary artery bypass surgery can be considered in this context. I-5 Several factors may be involved in the lack of demonstrable benefit with this study. The most important is the lack of significant renal impairment in all patients, as measured by free-water and creatinine clearance. Improvements in CPB perfusion techniques, fluid therapy, and more aggressive monitoring and intervention throughout the perioperative course have all led to a lower incidence of renal failure following cardiac surgery. For ethical reasons we could not restrict the use of fluid therapy, inotropes or vasodilators; we attempted to control the use of diuretics with a protocol to minimise confounding. None of these factors appears to adversely affect the interpretation of results. Secondly, this study may have lacked sufficient statistical power to detect a smaller difference. Using the creatinine clearance values at 20-24 hours, power analysis reveals a sample size of 980 patients would be required to demonstrate a difference (type 1 error= 0.05, type 11 error = 0.20), if in fact a difference exists. However, scrutiny of the results fails to even suggest a consistent trend of benefit, despite the reputed predictive ability or sensitivity of free-water and creatinine clearance. Dopamine was found to be less beneficial (though not significantly) than control for urine production and free-water clearance at four hours; however, these variables are related to each other, so the assumption of independence using analysis of variance may not be valid.
The haemodynamic effects of dopamine have been well described previously. Our study demonstrates similar effects, predominantly increased cardiac index and decreased systemic vascular resistance index. These changes would appear to be beneficial to circulatory function, particularly following coronary artery surgery. However, the ideal inotrope following CPB is still disputed, 19 and perhaps low doses of any inotrope would achieve the same haemodynamic end points.
Why have previously published reports found benefit with low-dose dopamine in preventing or reversing renal failure?11-I8 Oliguria is often considered the first manifestation of renal failure. In many of these cases there had been a degree of hypovolaemia, with resultant renal vasoconstriction and tubular reabsorption. Optimisation of intravascular fluid status is often administered before, or during institution of dopamine therapy. The haemodynamic effects of increased blood flow with vasodilation (particularly renal vessels), associated with increased intravascular volume, improves urine production. A stage is probably reached where this situation becomes irreversible and the patient develops established acute renal failure. Dopamine may have a role in preventing this progression.
Use of dopamine after cardiac surgery has been reported in children and adults. 14, 16, 17, [19] [20] [21] However, the issue of whether its routine use (especially pre-CPB) improves renal function or prevents renal failure has not previously been adequately addressed. Our study would suggest that the routine use of renal-dose dopamine in coronary artery surgery will not significantly improve renal function, nor prevent renal failure. The early detection of renal failure, correction of intravascular fluid status, minimal use of nephrotoxic drugs, and consideration of a low-dose dopamine infusion in the setting of oliguria, are all very important. This study was not designed to look specifically at high-risk patients, such as those with pre-existing renal impairment,S,21 or those with poor ventricular function. [1] [2] [3] [4] The ability for prophylactic renal-dose dopamine to prevent development of acute renal failure in these groups of patients is yet to be determined.
